Biotech Fundraising A Good Sign For Public Markets
By Yeji Jesse Lee · January 27, 2026, 7:04 PM EST
At the start of what many healthcare attorneys hope will be a busy year, public biotechs are raising cash, signaling a thawing public market and potentially fertile ground for IPOs....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login